Radiosurgical management of cavernous sinus hemangioma: Systematic Review, Meta-analysis, and International Stereotactic Radiosurgery Society Practice Guideline
Abstract
BACKGROUND
Cavernous sinus hemangiomas (CSHs) are rare benign vascular tumors and surgical resection carries substantial risks of morbidity and mortality. Stereotactic radiosurgery (SRS) and fractionated SRS (FSRS) have emerged as an effective non-invasive surgical alternative; however, appropriate patient selection, dosing, and outcomes remain unclear and underreported.
METHODS
A systematic review and meta-analysis was conducted following PRISMA guidelines to evaluate the efficacy and safety of SRS/FSRS for CSHs. A comprehensive literature search of PubMed and EMBASE was performed of peer-reviewed studies reporting outcomes of SRS or FSRS (≤5 fractions) in patients with histologically or radiographically-confirmed CSH published from January 1999 to August 2024. Primary outcomes included local tumor control (LC) and radiographic response, while secondary outcomes assessed symptom improvement and treatment-related toxicities.
RESULTS
A TOTAL OF 16 STUDIES COMPRISING 324 PATIENTS WERE INCLUDED: 14 SRS (282 patients) and 2 FSRS (42 patients). The crude LC was 100% in the entire cohort and the pooled substantial radiographic response rate (>50% reduction) was 85.0% (95% CI: 68-94%, I² = 67%) for 14 studies. Among those with symptoms (13 studies, 202 patients), the pooled symptom improvement rate was 98.0% (95% CI: 87.0-100.0%, I2 < 1%). Meta-regression revealed a significant positive association between definitive SRS/FSRS and symptom improvement (vs. adjuvant treatment).…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 324 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.